Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction

Abstract

Aging is a complex physiological process that poses considerable conundrums to rapidly aging societies. For example, the risk of dying from cardiovascular diseases and/or cancer steadily declines for people after their 60s, and other causes of death predominate for seniors older than 80 years of age. Thus, physiological aging presents numerous unanswered questions, particularly with regard to changing metabolic patterns. Urine proteomics analysis is becoming a non-invasive and reproducible diagnostic method. We investigated the urine proteomes in healthy elderly people to determine which metabolic processes were weakened or strengthened in aging humans. Urine samples from 37 healthy volunteers aged 19–90 years (19 men, 18 women) were analyzed for protein expression by liquid chromatography–tandem mass spectrometry. This generated a list of 19 proteins that were differentially expressed in different age groups (young, intermediate, and old age). In particular, the oldest group showed protein changes reflective of altered extracellular matrix turnover and declining immune function, in which changes corresponded to reported changes in cardiovascular tissue remodeling and immune disorders in the elderly. Thus, urinary proteome changes in the elderly appear to reflect the physiological processes of aging and are particularly clearly represented in the circulatory and immune systems. Detailed identification of “protein trails” creates a more global picture of metabolic changes that occur in the elderly.Electronic supplementary materialThe online version of this article (doi:10.1007/s11357-013-9562-7) contains supplementary material, which is available to authorized users.

Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria

“…It is possible that the older control subjects may have had other age-related sub-clinical conditions resulting in low grade inflammation, modest immune system disturbances, or moderate age-related decline in GFR. 39 However, we did not observe a skewed proteome profile in the cohort when compared to PH1 or IHC. The controls were known to be otherwise healthy and were screened to eliminate individuals taking prescriptions or over the counter medications on a regular basis, since their medical records were released for our review.…”

Proteome analysis in the assessment of ageing

“…A very recent study investigated the human urinary proteome in 37 healthy subjects (19 male and 18 female) between the age of 19 and 90 years (Bakun et al, 2014). Urine samples were analysed using LC-MS/MS and 19 proteins involved in tissue remodelling (e.g.…”

“…SPARC promotes tissue repair and differentiation (Wang et al, 2006). Therefore, reduced levels of SPARC may suggest alterations in the ECM and an impairment of tissue healing properties during ageing (Bakun et al, 2014). Levels of EGF-containing fibulin-like extracellular matrix protein or fibulins were also reported to reduce in the urine of older subjects.…”

How to diagnose and follow patients with glomerulonephritis without kidney biopsy?

“…We still do not know how most of the studied markers behave in the above condi tions, let alone others. While acknowledging the results of studies published so far, including our own studies, 4,5,9,[12][13][14] there is still a clear need for integration of these results.…”